Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain.

ABSTRACT:

Background

There are scarce data of the costs of non-small cell lung cancer (NSCLC) recurrence in Spain. The objective of this study is to assess the economic burden of disease recurrence, for both locoregional and/or metastatic relapses, after appropriate early-stage NSCLC treatment in Spain.

Materials and methods

A two-round consensus panel of Spanish oncologists and hospital pharmacists was conducted to collect information on patient's flow, treatments, use of healthcare resources and sick leaves in patients with relapsed NSCLC. A decision-tree model was developed to calculate the economic burden of disease recurrence after appropriate early-stage NSCLC. Both direct and indirect costs were considered. Direct costs included drug acquisition and healthcare resources costs.

SUBMITTER: De Castro J 

PROVIDER: S-EPMC9942326 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature